Izinga le-Triglyceride
Izinga le-triglyceride ukuhlolwa kwegazi ukukala inani lama-triglycerides egazini lakho. I-Triglycerides uhlobo lwamafutha.
Umzimba wakho wenza amanye ama-triglycerides. Ama-Triglycerides nawo avela ekudleni okudlayo. Amakholori angeziwe aphendulwa ama-triglycerides futhi agcinwa kumaseli anamafutha ukuze asetshenziswe kamuva. Uma udla ama-calories amaningi kunalokho okudingwa ngumzimba wakho, izinga lakho le-triglyceride lingaba phezulu.
Ukuhlolwa kwamazinga aphezulu we-cholesterol egazini kuyisilinganiso esihlobene.
Kudingeka isampula yegazi. Isikhathi esiningi, igazi likhishwa emthanjeni ongaphakathi endololwaneni noma ngemuva kwesandla.
Akufanele udle amahora ayisishiyagalombili kuya kwayi-12 ngaphambi kokuhlolwa.
Utshwala neminye imithi kungaphazamisa imiphumela yokuhlolwa kwegazi.
- Qiniseka ukuthi umhlinzeki wakho wezokunakekelwa kwempilo uyazi ukuthi imiphi imithi oyisebenzisayo, kufaka phakathi imishanguzo yokuthenga kanye nezengezo.
- Umhlinzeki wakho uzokutshela uma udinga ukuyeka ukuthatha noma yimiphi imithi ngaphambi kokwenza lokhu kuhlolwa.
- UNGAYIMISI noma ushintshe imithi yakho ngaphandle kokukhuluma nomhlinzeki wakho kuqala.
Ungase uzwe ubuhlungu obuncane noma isitinyela lapho kufakwa inaliti. Ungase futhi uzizwe ushaywa yisiza ngemuva kokukhishwa kwegazi.
Ama-Triglycerides ngokuvamile alinganiswa ndawonye namanye amafutha egazi. Imvamisa kwenziwa ukusiza ukuthola ubungozi bokuba nesifo senhliziyo. Izinga eliphezulu le-triglyceride lingaholela ku-atherosclerosis, okwandisa ingozi yokuhlaselwa yisifo senhliziyo nokushaywa unhlangothi.
Izinga eliphezulu kakhulu le-triglyceride lingadala nokuvuvukala kwamanyikwe akho (okuthiwa i-pancreatitis).
Imiphumela ingakhombisa:
- Okuvamile: Ngaphansi kuka-150 mg / dL
- Ukuphakama komngcele: 150 kuya ku-199 mg / dL
- Okuphezulu: 200 kuya ku-499 mg / dL
- Kuphezulu kakhulu: 500 mg / dL noma ngaphezulu
Ububanzi bamanani ajwayelekile bungahluka kancane phakathi kwamalabhorethri ahlukene. Khuluma nomhlinzeki wakho mayelana nencazelo yemiphumela yakho ethile yokuhlolwa.
Izibonelo ezingenhla zibonisa izilinganiso ezivamile zemiphumela yalezi zivivinyo. Amanye ama-laboratories asebenzisa izilinganiso ezahlukahlukene noma angahlola izinhlobo ezahlukene.
Amazinga aphezulu e-triglyceride angabangelwa:
- Ukulimala kwesibindi noma ukulimala kwesibindi
- Ukudla okungenawo amaprotheni amaningi kanye nama-carbohydrate aphezulu
- I-thyroid engasebenzi
- I-Nephrotic syndrome (ukuphazamiseka kwezinso)
- Eminye imithi, efana namahomoni abesifazane
- Isifo sikashukela esilawulwa kabi
- Ukuphazamiseka kudluliselwa emindenini lapho kukhona inani eliphakeme le-cholesterol ne-triglycerides egazini
Sekukonke, ukwelashwa kwamazinga aphakeme e-triglyceride kugxile ekwandiseni ukuzivocavoca umzimba kanye nezinguquko ekudleni. Izidakamizwa zokwehlisa amazinga we-triglyceride zingasetshenziswa ukuvimbela i-pancreatitis yamazinga angaphezu kwama-500 mg / dL.
Amaleveli aphansi e-triglyceride angabangelwa:
- Ukudla okunamafutha amancane
- I-Hyperthyroidism (i-thyroid engasebenzi ngokweqile)
- I-Malabsorption syndrome (izimo lapho amathumbu amancane engamunci kahle amafutha)
- Ukungondleki
Ukukhulelwa kungathinta imiphumela yokuhlolwa.
Ukuhlolwa kwe-Triacylglycerol
- Ukuhlolwa kwegazi
U-Arnett DK, uBlumenthal RS, u-Albert MA, et al. Umhlahlandlela we-2019 ACC / AHA ekuvinjelweni okuyinhloko kwesifo senhliziyo: umbiko we-American College of Cardiology / American Heart Association Task Force on Guidelines Practice Guidelines. Ukujikeleza. 2019; 140 (11): e596-e646. I-PMID: 30879355 pubmed.ncbi.nlm.nih.gov/30879355/.
UChen X, uZhou L, uHussain MM. I-Lipids ne-dyslipoproteinemia. Ku: McPherson RA, Pincus MR, abahleli. UHenry’s Clinical Diagnosis and Management by Laboratory Methods. Umhla ka-23. ISt Louis, MO: Elsevier; I-2017: isahluko 17.
UGenest J, ukuphazamiseka kweLibby P. Lipoprotein nesifo senhliziyo. Ku: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, Braunwald E, ama-eds. Isifo Senhliziyo SikaBraunwald: Incwadi Yemithi Yezinhliziyo Nemithambo. Umhla ka-11. IPhiladelphia, PA: Elsevier; 2019: isahluko 48.
I-Grundy SM, i-Stone NJ, i-Bailey AL, et al. 2018 AHA / ACC / AACVPR / AAPA / ABC / ACPM / ADA / AGS / APhA / ASPC / NLA / PCNA Guideline on the management of blood cholesterol: isifinyezo esiphezulu: umbiko we-American College of Cardiology / American Heart Association Task Force ku Imihlahlandlela Yokuzivocavoca Yomtholampilo. Ukujikeleza. 2019; 139 (25): e1046-e1081. I-PMID: 30565953 pubmed.ncbi.nlm.nih.gov/30565953/.
Ridker PM, Libby P, Buring JE. Izimpawu zobungozi kanye nokuvimbela okuyinhloko kwesifo senhliziyo. Ku: Zipes DP, Libby P, Bonow RO, Mann, DL, Tomaselli GF, Braunwald E, ama-eds. Isifo Senhliziyo SikaBraunwald: Incwadi Yemithi Yezinhliziyo Nemithambo. Umhla ka-11. IPhiladelphia, PA: Elsevier; 2019: isahluko 45.
URobinson JG. Ukuphazamiseka kwe-lipid metabolism. Ku: IGoldman L, iSchafer AI, ama-eds. Imithi yeGoldman-Cecil. Umhla ka-26. IPhiladelphia, PA: Elsevier; 2020: isahluko 195.